A new trading day began on Tuesday, with Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) stock price up 3.16% from the previous day of trading, before settling in for the closing price of $63.66. RYTM’s price has ranged from $36.27 to $68.58 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 37.85%. With a float of $58.22 million, this company’s outstanding shares have now reached $63.49 million.
The extent of productivity of a business whose workforce counts for 283 workers is very important to gauge. In terms of profitability, gross margin is 89.49%, operating margin of -126.13%, and the pretax margin is -123.16%.
Rhythm Pharmaceuticals Inc (RYTM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Rhythm Pharmaceuticals Inc is 8.48%, while institutional ownership is 95.55%. The most recent insider transaction that took place on Jun 03 ’25, was worth 4,165,337. Before that another transaction happened on Jun 03 ’25, when Company’s Director proposed sale 43,621 for $63.66, making the entire transaction worth $2,776,913.
Rhythm Pharmaceuticals Inc (RYTM) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 37.85% per share during the next fiscal year.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Trading Performance Indicators
Here are Rhythm Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 30.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.82, a number that is poised to hit -0.64 in the next quarter and is forecasted to reach -1.38 in one year’s time.
Technical Analysis of Rhythm Pharmaceuticals Inc (RYTM)
The latest stats from [Rhythm Pharmaceuticals Inc, RYTM] show that its last 5-days average volume of 0.52 million was inferior to 0.63 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 75.87%. Additionally, its Average True Range was 2.78.
During the past 100 days, Rhythm Pharmaceuticals Inc’s (RYTM) raw stochastic average was set at 97.92%, which indicates a significant increase from 97.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.98% in the past 14 days, which was lower than the 52.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $59.43, while its 200-day Moving Average is $55.42. Now, the first resistance to watch is $66.48. This is followed by the second major resistance level at $67.29. The third major resistance level sits at $68.69. If the price goes on to break the first support level at $64.27, it is likely to go to the next support level at $62.87. The third support level lies at $62.06 if the price breaches the second support level.
Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) Key Stats
With a market capitalization of 4.18 billion, the company has a total of 63,621K Shares Outstanding. Currently, annual sales are 130,130 K while annual income is -260,600 K. The company’s previous quarter sales were 32,700 K while its latest quarter income was -49,500 K.
